 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/13/2026 |
$94.14 |
$94.54 |
$92.78 |
$94.51 |
8.04M | | 01/14/2026 |
$96.02 |
$96.43 |
$95.37 |
$96.34 |
7.71M | | 01/15/2026 |
$95.30 |
$95.36 |
$93.41 |
$93.99 |
9.15M | | 01/16/2026 |
$94.47 |
$94.68 |
$93.51 |
$94.39 |
55.05M | | 01/20/2026 |
$90.14 |
$91.12 |
$89.17 |
$89.94 |
11.14M |
 |
| AstraZeneca PLC is a science-led biopharmaceutical company. It discovers, develops, and commercializes prescription medicines in oncology, rare diseases, and biopharmaceuticals, including cardiovascular, renal and metabolism, respiratory and immunology and vaccines and immune therapies. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its biopharmaceuticals products include Farxiga, Crestor, Breztri and others. Its investigational vaccine candidate IVX-A12, which targets both respiratory syncytial virus and human metapneumovirus. | |
 |

AstraZeneca (AZN) has the following price history information. Looking back at AZN historical stock prices for the last five trading days, on January 13, 2026, AZN opened at $94.14, traded as high as $94.54 and as low as $92.78, and closed at $94.51. Trading volume was a total of 8.04M shares. On January 14, 2026, AZN opened at $96.02, traded as high as $96.43 and as low as $95.37, and closed at $96.34. Trading volume was a total of 7.71M shares. On January 15, 2026, AZN opened at $95.30, traded as high as $95.36 and as low as $93.41, and closed at $93.99. Trading volume was a total of 9.15M shares. On January 16, 2026, AZN opened at $94.47, traded as high as $94.68 and as low as $93.51, and closed at $94.39. Trading volume was a total of 55.05M shares. On January 20, 2026, AZN opened at $90.14, traded as high as $91.12 and as low as $89.17, and closed at $89.94. Trading volume was a total of 11.14M shares.
AZN Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into AstraZeneca shares, starting with a $10,000 purchase of AZN, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
01/22/2016 |
|
| End date: |
01/20/2026 |
|
| Start price/share: |
$31.48 |
|
| End price/share: |
$89.94 |
|
| Starting shares: |
317.66 |
|
| Ending shares: |
431.80 |
|
| Dividends reinvested/share: |
$14.35 |
|
| Total return: |
288.36% |
|
| Average Annual Total Return: |
14.53% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$38,846.69 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/22/2016 |
|
| End date: |
01/20/2026 |
|
| Start price/share: |
$31.48 |
|
| End price/share: |
$89.94 |
|
| Dividends collected/share: |
$14.35 |
|
| Total return: |
231.29% |
|
| Average Annual Total Return: |
12.72% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$33,124.72 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 01/13/2026 | $94.51 | | 01/14/2026 | $96.34 | | 01/15/2026 | $93.99 | | 01/16/2026 | $94.39 | | 01/20/2026 | $89.94 |
|
 |